Nådde inte upp till förväntningarna

I sin delårsrapport redovisar Astrazeneca ett rekord i produktgodkännanden – men analytikerna är besvikna.

Cate Poulsen, Qiagen

Why are you going to Scanlab and Biotech Forum?

Antikropp mot leukemi

Genmab och Glaxosmithkline har ansökt om marknadsgodkännande hos EMEA för det biologiska leukemiläkemedlet Arzerra, med aktiv substans ofatumumab.

Dry blood DNA storage on a matrix

Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.

EU har siktet på Lundbeck

EU-kommissionen kommer att granska om den danska läkemedelsjätten har brutit mot EUs regler för konkurrens. Granskningen gäller hur Lundbeck har agerat kring ge...

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Top modern lab to Sahlgrenska

The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.

Upp och ner under det andra kvartalet

Astrazeneca, Probi och Recipharm är några av de bolag som visade upp positiva rapporter från det andra kvartalet i juli månad. Sämre gick det bland annat för Orexo.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

Printing sensors for biological samples

Acreo develops technologies for printed electronics. Using organic printers, Acreo can print a transistor where biological samples can be placed.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

Novo och Astra ligger bra till i internationell kraftmätning

Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

LEO Pharma - International Clinical Trial Manager

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...

”Alla skriker efter talang”

Att locka till sig begåvningarna är en av life science-branschens stora framtidsutmaningar. Det var en av slutsatserna i det panelsamtal som avslutade konferensen New Horizons in Biologics & Bioprocessing på torsdagen....

Konferens om läkemedelsformuleringar samlar branschen i Köpenhamn

Idag pågår den tionde upplagan av New Updates in Drug Formulation & Bioavailability 2022 i Köpenhamn.